|
Delayed
Berne S.E.
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | - |
| 04:36pm | PTC Therapeutics Retains Significant Firepower for Bolt-On Deals, RBC Capital Markets Says | MT |
| 09-21 | PTC Therapeutics Closes Acquisition of the ST-920 Gene Therapy for Fabry Disease | MT |
| Market Cap | 5.32B 4.75B 4.43B 4.03B 7.58B 514B 7.64B 53.26B 20.81B 262B 19.96B 19.53B 841B | P/E 2026 * |
41.3x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.45B 3.08B 2.87B 2.61B 4.91B 333B 4.95B 34.51B 13.48B 170B 12.93B 12.65B 545B | EV / Sales 2026 * |
2.74x | EV / Sales 2027 * | 2.3x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: PTC Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 54 | 21/03/2023 |
Pierre Gravier
DFI | Director of Finance/CFO | 41 | 12/07/2023 |
| Chief Tech/Sci/R&D Officer | - | 30/09/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 31/10/2004 | |
Allan Jacobson
CHM | Chairman | 80 | 30/03/1998 |
David Southwell
BRD | Director/Board Member | 65 | 30/11/2005 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 5.32B | |
| +2.70% | +2.73% | +40.91% | +107.91% | 1,032B | |
| +1.44% | -2.38% | +36.83% | +63.02% | 614B | |
| +1.75% | +3.73% | +16.55% | +81.99% | 471B | |
| +0.60% | -1.73% | +62.98% | +36.64% | 350B | |
| +2.92% | +3.06% | +24.83% | +45.10% | 337B | |
| +2.42% | -0.74% | +13.44% | +35.80% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.60% | -2.00% | +39.77% | +52.12% | 218B | |
| +1.82% | -1.48% | +25.75% | +95.64% | 179B | |
| Average | +1.64% | -3.39% | +28.48% | +58.94% | 412.76B | |
| Weighted average by Cap. | +2.00% | -3.18% | +31.96% | +69.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.12B 1.05B 952M 1.79B 122B 1.81B 12.6B 4.92B 61.88B 4.72B 4.62B 199B | 1.38B 1.23B 1.15B 1.04B 1.96B 133B 1.98B 13.79B 5.39B 67.74B 5.17B 5.06B 218B |
| Net income | 145M 130M 121M 110M 207M 14.07B 209M 1.46B 569M 7.15B 546M 534M 23B | 218M 195M 182M 165M 311M 21.12B 314M 2.19B 855M 10.74B 820M 802M 34.54B |
| Net Debt | -1.87B -1.67B -1.56B -1.42B -2.67B -181B -2.69B -18.74B -7.32B -92.05B -7.02B -6.87B -296B | -2.15B -1.92B -1.79B -1.62B -3.06B -208B -3.08B -21.49B -8.4B -106B -8.05B -7.88B -339B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTCT Stock
- P91 Stock
Select your edition
All financial news and data tailored to specific country editions
